We are committed to participating in as many existing IBD trials as possible to provide the best treatment opportunities for our patients.
Our goal is to contribute to the research that will one day find a cure for IBD, and in the meantime, to help our patients live more fulfilling, symptom-free lives.
Active Crohn's clinical trials
New medical therapies in the IBD pipeline (for patients who have failed steroids, immunomodulators and/or biologic therapy)
-
ADVANCE
-
MOTIVATE
-
U-Exceed
-
Yellowstone
-
POWER
Early diagnosis/treatment of Crohn's
-
Explorer
For patients with moderate to severe Crohn's or fistulizing Crohn's patients
-
GALAXI
Active Ulcerative Colitis clinical trials
-
INSPIRE
-
U-Achieve
-
QUASAR
Miscellaneous trials
-
TARGET